These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Amlodipine + valsartan + hydrochlorothiazide. A 3-drug fixed-dose combination for hypertension: too many drawbacks. Prescrire Int; 2011 Mar 01; 20(114):67. PubMed ID: 21648225 [No Abstract] [Full Text] [Related]
3. Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination? Barrios V, Escobar C. Expert Rev Cardiovasc Ther; 2010 Nov 01; 8(11):1609-18. PubMed ID: 21090936 [Abstract] [Full Text] [Related]
4. [Effective blood pressure control with a fixed combination]. Bäurle A. MMW Fortschr Med; 2016 May 25; 158(10):84. PubMed ID: 27221444 [No Abstract] [Full Text] [Related]
5. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D. Clin Ther; 2005 May 25; 27(5):578-87. PubMed ID: 15978306 [Abstract] [Full Text] [Related]
7. Exforge HCT. Med Lett Drugs Ther; 2009 Jun 15; 51(1314):47. PubMed ID: 19528888 [No Abstract] [Full Text] [Related]
8. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database. Jackson KC, Sheng X, Nelson RE, Keskinaslan A, Brixner DI. Clin Ther; 2008 Aug 15; 30(8):1558-63. PubMed ID: 18803997 [Abstract] [Full Text] [Related]
9. Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety. Calhoun DA, Crikelair NA, Yen J, Glazer RD. Adv Ther; 2009 Nov 15; 26(11):1012-23. PubMed ID: 20024680 [Abstract] [Full Text] [Related]
11. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension. Frampton JE, Scott LJ. Am J Cardiovasc Drugs; 2009 Nov 15; 9(5):309-30. PubMed ID: 19791840 [Abstract] [Full Text] [Related]
14. Targeting hypertension with valsartan: Lessons learned from the Valsartan/HCTZ versus Amlodipine in stage II hypertensive patients (VASt) trial. Ruilope LM, Zanchetti A. J Renin Angiotensin Aldosterone Syst; 2006 Jun 15; 7 Suppl 1():S8-11. PubMed ID: 16986228 [Abstract] [Full Text] [Related]
15. Valsartan/hydrochlorothiazide: pharmacology and clinical efficacy. Kondrack R, Mohiuddin S. Expert Opin Drug Metab Toxicol; 2009 Sep 15; 5(9):1125-34. PubMed ID: 19689218 [Abstract] [Full Text] [Related]
16. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine. Ferri C, Croce G, Desideri G. Adv Ther; 2008 Apr 15; 25(4):300-20. PubMed ID: 18449492 [Abstract] [Full Text] [Related]
17. [VALUE study underscores the significance of reaching aimed blood pressure values for minimizing cardiovascular risks]. Praxis (Bern 1994); 2004 Oct 13; 93(42):1748. PubMed ID: 15529964 [No Abstract] [Full Text] [Related]
18. Two amlodipine/ARB combinations for hypertension. Med Lett Drugs Ther; 2007 Dec 17; 49(1276):101-2. PubMed ID: 18084152 [No Abstract] [Full Text] [Related]
19. [Blood pressure lowering and risk reduction under treatment with valsartan and its combination with hydrochlorothiazide (HCT)]. Scholze J, Müller U. MMW Fortschr Med; 2006 Oct 19; 148(42):48. PubMed ID: 17621800 [No Abstract] [Full Text] [Related]
20. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial. Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y. Clin Ther; 2005 Jul 19; 27(7):1013-21. PubMed ID: 16154480 [Abstract] [Full Text] [Related] Page: [Next] [New Search]